EU Regulator Urges Firms To Up Their Game On Drug Shortages
Executive Summary
New guidance from the European Medicines Agency is calling on supply chain participants to be more proactive in forecasting and notifying medicine shortages, while a group of EU member states has said that “more drastic steps” need to be taken to improve the security of medicines supply.
You may also be interested in...
Denmark: Critical Medicines List To Make Supply Shortage Notifications Easier
The Danish drug regulator says its new critical medicines list and notification form will make it easier for companies to notify the agency of supply shortages.
US Drug Shortages Aid Aurobindo’s Q4 Growth, Decentralized Trials On For Xolair Biosimilar
Drug shortages, stable prices and a demand recovery in the US helped drive Aurobindo’s growth in Q4. Meanwhile, the company is developing a biosimilar to Roche/Novartis’s multi-billion product Xolair. Use of decentralized mode for its Phase III trials is a notable aspect.
US Drug Shortages Aid Aurobindo’s Q4 Growth, Decentralized Trials On For Xolair Biosimilar
Drug shortages, stable prices and a demand recovery in the US helped drive Aurobindo’s growth in Q4. Meanwhile, the company is developing a biosimilar to Roche/Novartis’s multi-billion product Xolair, as predicted by Scrip earlier. Use of decentralized mode for its Phase III trials is a notable aspect